Feedback Survey

Is the RACGP your CPD home?
Is AMA CPD Home your CPD home?

Activity Title: Authorised Prescriber Course / Cannabinoid Medicine for General Practice

Activity No. 824104, allocated 8 CPD hours in the RACGP 2023-25 CPD program

Please rate to what degree the learning outcomes of the program were met:
1. Explain the pathophysiology of the human body's endocannabinoid system.
2. Recall common constituents of cannabinoid base medications.
3. Identify current Australian TGA guidelines for the use of cannabinoid-based medicines used for common presentations.
4. Determine safety considerations in prescribing and titrating cannabinoid-based medications.
5. Summarise best practice recommendations in medication selection, dosing, and titration for cannabinoid-based treatments.
6. Describe appropriate TGA prescribing pathways and resources.
7. Identify key health professionals to collaborate with in a multidisciplinary setting to support patients.
8. Evaluate and communicate best practices for the daily administration of medicinal cannabis to patients.
9. Please rate what degree this activity was relevant to your practice:
10. Does this activity motivate you to change systems, processes in your practice that would improve patient or practice safety and/or care?
Please rate to what degree this CPD activity met your expectation about:
11. Content – Current, contemporary, evidence-based, and relevant to general practice
12. Delivery – Engaging/interactive, eg with opportunity for questions and feedback
13. For live: Presenters/Facilitators – Engaging, qualified/skilled and knowledgeable For eLearning: Learning Management System is user friendly and easily navigated to achieve Learning Outcomes.
14. Would you likely recommend this CPD activity to a colleague?  
15. Would you likely change anything in your practice as a result of this CPD activity?